Human Phenotype Ontology 
Grandparent Node:
expandAbnormal platelet aggregation (HP:0030402)help
Parent Node:
expandImpaired platelet aggregation (HP:0003540)help
..Starting node
..expandImpaired thromboxane A2 agonist-induced platelet aggregation (HP:0011894)help
Term ID: 11894
Name: Impaired thromboxane A2 agonist-induced platelet aggregation
Synonym:
Definition: Abnormal response to thromboxane as manifested by reduced or lacking aggregation of platelets upon addition of thromboxane A2 receptor agonists.
Comments:
Reference: HP:0011894
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandImpaired ADP-induced platelet aggregation (HP:0004866) help
..expandImpaired arachidonic acid-induced platelet aggregation (HP:0011870) help
..expandImpaired calcium ionophore-induced platelet aggregation (HP:0031130) help
..expandImpaired collagen-induced platelet aggregation (HP:0008320) help
..expandImpaired collagen-related peptide-induced platelet aggregation (HP:0031128) help
..expandImpaired convulxin-induced platelet aggregation (HP:0031127) help
..expandImpaired epinephrine-induced platelet aggregation (HP:0008148) help
..expandImpaired phorbol myristate acetate-induced platelet aggregation (HP:0031129) help
..expandImpaired ristocetin-induced platelet aggregation (HP:0011871) help
..expandImpaired thrombin-induced platelet aggregation (HP:0011872) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0011894HP:0011894Impaired thromboxane A2 agonist-induced platelet aggregation0TBXA2R CL E G H691511608OMIM:614009BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT1310


Genes (1) :TBXA2R

Diseases (1) :OMIM:614009
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.